bioRxiv Science⌕ Search

bioRxiv · 10.1101/371138

Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction

Abstract

ImportanceThe third Universal Definition of Myocardial Infarction aimed to standardize the approach to the diagnosis and management of myocardial infarction. High-sensitivity cardiac troponin testing was recommended, as these assays have improved precision at low concentrations, but concerns over specificity may have limited implementation.\n\nObjectiveTo determine the global adoption of high-sensitivity cardiac troponin assays and key recommendations from the Universal Definition.\n\nDesign, Setting and ParticipantsGlobal survey of 1,902 medical centers across 23 countries evenly distributed across all five continents. Included respondents were involved in the diagnosis and management of patients with suspected acute coronary syndrome at their institutions.\n\nMain Outcomes and MeasuresStructured questionnaire detailing the primary biomarker used for myocardial infarction, diagnostic thresholds and critical elements of clinical pathways for comparison to the third Universal Definition recommendations.\n\nResultsCardiac troponin was the primary diagnostic biomarker for myocardial infarction at 96% of all sites surveyed. Only 41% of centers had adopted high-sensitivity cardiac troponin assays, with wide variation from 7% in North America to 60% in Europe. Sites using high-sensitivity assays more frequently employed serial sampling pathways (91% vs. 78%) and the 99th percentile diagnostic threshold (74% vs. 66%) when compared to sites using the previous generation of troponin assays. Furthermore, sites using high-sensitivity assays more often used earlier serial sampling ([≤]3 hours) and accelerated diagnostic pathways. However, fewer than 1 in 5 sites using high-sensitivity assays had adopted sex-specific thresholds (18%).\n\nConclusions and RelevanceProgress has been made in adopting the recommendations of the Universal Definition of Myocardial Infarction, particularly in the use of the 99th percentile diagnostic threshold and serial sampling. However, high-sensitivity assays are used in a minority of sites and sex-specific thresholds in even fewer. These findings highlight regions where additional efforts are required to improve the risk stratification and diagnosis of patients with myocardial infarction.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Anand, A., Shah, A. S., Beshiri, A., Jaffe, A. S., Mills, N. L.. 2018-07-17. Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction. https://doi.org/10.1101/371138

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Direct Bioconjugations of Diverse Payloads using an Extraordinarily Donor-Promiscuous Flavin Transferase

Site-specific protein conjugation is a widely used tool in chemical biology research and is the foundation of many biotechnological and biomedical applications. A key enabling technology are repurposed post-translational protein modifying enzymes, where variants with broad donor and acceptor substrate promiscuity were developed into general-purpose bioconjugation platforms. However, direct enzymatic attachment of bulky or structurally diverse payloads is often limited by low reaction efficiencies and difficulties in preparing suitable donors. Consequently, conjugation typically relies on two-step strategies in which an enzyme first installs a bioorthogonal handle on the target protein, followed by chemical attachment of the payload. These enzyme-first, chemistry-second approaches limit chemistry to bioorthogonal reactions that leave a molecular footprint. Here, we introduce direct ADDing, an enzymatic bioconjugation platform based on our discovery of the exceptional donor promiscuity of the flavin transferase ApbE. We show that ApbE accepts a remarkably broad range of donor substrates provided they carry an adenosine diphosphate (ADP) anchor. The prevalence of ADP-containing compounds in nature provides access to diverse building blocks and an extensive biochemical toolbox for donor generation. Exploiting these resources, we demonstrate multiple strategies for preparing compatible donors and achieve direct, site-specific enzymatic conjugation of diverse small molecules, peptides, proteins, and synthetic polymers.

biochemistry↗

A respiratory microdomain links ubiquinone biosynthesis to succinate dehydrogenase in an apicomplexan mitochondrion lacking Complex I

Mitochondrial complex I (CI) is a major entry point for NADH-derived electrons and an important site of redox regulation in most eukaryotes. However, apicomplexan parasites, including Toxoplasma gondii, lack CI, raising a fundamental question of how mitochondrial respiration is organized in these parasites. Here, we identify a parasite-specific mitochondrial microdomain that physically and functionally couples ubiquinone (UQ) biosynthesis to succinate dehydrogenase (SDH). Using proximity labeling, membrane-based yeast two-hybrid analyses, reciprocal co-immunoprecipitations, and blue native PAGE, we show that UQ biosynthesis proteins associate with parasite-specific SDH subunits and co-migrate as a high-molecular-weight assembly. Knockdown of TgCoq4, a component of the UQ biosynthesis pathway, reduced SDH activity, and adding exogenous UQ to the assay did not restore it, indicating that UQ availability is not sufficient for efficient succinate oxidation. FCCP stimulates malate- and TMPD/ascorbate-supported respiration to maximal capacity but fails to do so with succinate as the substrate. This result, combined with reactive oxygen species (ROS) data, suggests that succinate causes over-reduction of the UQ pool, limiting further electron flow. We also find that CIII associates with the UQ synthesis machinery, suggesting a larger protein assembly. Together, these findings reveal that UQ biosynthesis and electron transport are physically and functionally integrated in T. gondii, defining a previously unrecognized organization of mitochondrial respiration in an organism lacking CI.

biochemistry↗

Human senataxin uses distinct peripheral elements to unwind R-loops and act on RNA polymerase II

Persistent R-loops and paused or stalled RNA polymerase II (RNAPII) elongation complexes can threaten genome stability. Senataxin (SETX) contributes to R-loop resolution and RNAPII regulation, but their intimate connection during transcription makes the individual contributions of these activities difficult to distinguish in cells. To determine whether these activities rely on the same molecular features, we investigated the structure and biochemical properties of the SETX helicase domain (SETX-HD). Cryo-EM defines the conserved helicase core and RNA-binding channel of SETX-HD, while biochemical analyses identify distinct roles for two peripheral elements: a previously uncharacterised C-terminal RNA-binding domain (CT-RBD) and the prong subdomain. In reconstituted mammalian transcription assays, SETX-HD promotes passage beyond a defined RNAPII pause and elongation-complex dissociation on the same template. The CT-RBD stabilises RNA engagement and is required for efficient R-loop unwinding, whereas its deletion preserves both RNAPII-associated activities. Conversely, replacing the native SETX prong with its fungal Sen1 counterpart preserves R-loop unwinding but impairs both RNAPII outcomes. These reciprocal separation-of-function effects establish that a common SETX-HD RNA-translocation core depends on distinct peripheral elements for R-loop unwinding and action on mammalian RNAPII. This separation provides a direct route to determine how these activities contribute to SETX function in cells.

biochemistry↗